Illuminare Biotechnologies
$600.0K
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Illuminare Biotechnologies is currently valued at N/A as of May 21, 2025. The company has raised a total of $7.1M in funding.
Investment Perspective
Illuminare Biotechnologies's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Illuminare Biotechnologies Worth in 2025?
As of 2025, Illuminare Biotechnologies is valued at N/A, based on the company's Later Stage VC funding round in May 21, 2025. This valuation positions Illuminare Biotechnologies as one of the leading private companies in the sector.
Illuminare Biotechnologies Valuation History
Illuminare Biotechnologies's funding history demonstrates steady growth and investor confidence.
How Illuminare Biotechnologies Valuation is Determined
Private company valuations like Illuminare Biotechnologies's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Illuminare Biotechnologies Valuation FAQs
Is Illuminare Biotechnologies profitable?
Illuminare Biotechnologies has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Illuminare Biotechnologies's valuation compare to competitors?
Illuminare Biotechnologies is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Illuminare Biotechnologies IPO?
Illuminare Biotechnologies has not announced plans for an initial public offering. Until an IPO, investors can access Illuminare Biotechnologies shares through secondary market platforms.